Multiple sclerosis

2,419,425views

Multiple sclerosis

NMSK 2022

NMSK 2022

Anatomical terminology
Introduction to the central and peripheral nervous systems
Introduction to the somatic and autonomic nervous systems
Development of the axial skeleton
Bones of the vertebral column
Joints of the vertebral column
Muscles of the back
Vessels and nerves of the vertebral column
Anatomy clinical correlates: Bones, joints and muscles of the back
Superficial structures of the neck: Posterior triangle
Deep structures of the neck: Root of the neck
Anatomy clinical correlates: Vessels, nerves and lymphatics of the neck
Bones of the upper limb
Development of the limbs
Fascia, vessels and nerves of the upper limb
Muscles of the hand
Anatomy of the arm
Anatomy of the brachial plexus
Brachial plexus
Bones of the lower limb
Fascia, vessels and nerves of the lower limb
Muscles of the gluteal region and posterior thigh
Compartment syndrome
Sciatica
Bone remodeling and repair
Ectoderm
Skin histology
Skin anatomy and physiology
Skin and soft tissue infections: Clinical
Papulosquamous and inflammatory skin disorders: Pathology review
Eczematous rashes: Clinical
Skin cancer: Pathology review
Skin cancer: Clinical
Bone histology
Skeletal system anatomy and physiology
Bone disorders: Pathology review
Bone tumors: Pathology review
Paget disease of bone
Pediatric bone and joint infections: Clinical
Joint pain: Clinical
Gout
Rheumatoid arthritis
Nervous system anatomy and physiology
Neuromuscular junction and motor unit
Neuromuscular blockers
Skeletal muscle histology
Muscular system anatomy and physiology
Muscle contraction
Sliding filament model of muscle contraction
Muscle spindles and golgi tendon organs
Neuromuscular junction disorders: Pathology review
Muscle weakness: Clinical
Sympathetic nervous system
Parasympathetic nervous system
Adrenergic receptors
Cholinergic receptors
Opioid agonists, mixed agonist-antagonists and partial agonists
Cholinomimetics: Direct agonists
Substance misuse and addiction: Clinical
Pharmacodynamics: Desensitization and tolerance
Bones of the cranium
Anatomy of the cranial base
Anatomy of the orbit
Anatomy of the eye
Photoreception
Fascia and spaces of the neck
Superficial structures of the neck: Anterior triangle
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Pharyngeal arches, pouches, and clefts
Development of the face and palate
Development of the nervous system
Anatomy of the brainstem
Broca aphasia
Wernicke aphasia
Memory
Cerebrospinal fluid
Normal pressure hydrocephalus
Anatomy of the blood supply to the brain
Introduction to the cranial nerves
Cranial nerves
Cranial nerve pathways
Spina bifida
Congenital neurological disorders: Pathology review
Meningitis, encephalitis and brain abscesses: Clinical
Meningitis
Brain abscess
Encephalitis
Spinal cord disorders: Pathology review
Sensory receptor function
Somatosensory receptors
Anatomy of the ascending spinal cord pathways
Anatomy of the descending spinal cord pathways
Anatomy clinical correlates: Spinal cord pathways
Somatosensory pathways
Vitamin B12 deficiency
Motor cortex
Pyramidal and extrapyramidal tracts
Brown-Sequard Syndrome
Syringomyelia
Cauda equina syndrome
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Amyotrophic lateral sclerosis
Olfactory transduction and pathways
Trigeminal neuralgia
Bell palsy
Optic pathways and visual fields
Pituitary adenoma
Anatomy of the oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Vestibulo-ocular reflex and nystagmus
Vestibular transduction
Cerebellum
Dizziness and vertigo: Clinical
Basal ganglia: Direct and indirect pathway of movement
Essential tremor
Huntington disease
Parkinson disease
Movement disorders: Pathology review
Anti-parkinson medications
Medications for neurodegenerative diseases
Hypokinetic movement disorders: Clinical
Multiple sclerosis
Leukodystrophy
Sleep
Toxidromes: Clinical
Cerebral vascular disease: Pathology review
Saccular aneurysm
Intracerebral hemorrhage
Arteriovenous malformation
Ischemic stroke
Transient ischemic attack
Anatomy clinical correlates: Posterior blood supply to the brain
Stroke: Clinical
Epidural hematoma
Brain herniation
Traumatic brain injury: Clinical
Traumatic brain injury: Pathology review
Concussion and traumatic brain injury
Adult brain tumors
Brain tumors: Clinical
Cluster headache
Tension headache
Migraine
Cavernous sinus thrombosis
Idiopathic intracranial hypertension
Migraine medications
Antidiuretic hormone
Hypoprolactinemia
Growth hormone and somatostatin
Oxytocin and prolactin
Anatomy of the limbic system
Frontotemporal dementia
Dementia with Lewy bodies
Vascular dementia
Creutzfeldt-Jakob disease
Syncope: Clinical
Amnesia

Transcript

Watch video only

Content Reviewers

Multiple sclerosis is a demyelinating disease of the central nervous system, which includes the brain and the spinal cord.

Myelin is the protective sheath that surrounds the axons of neurons, allowing them to quickly send electrical impulses.

This myelin is produced by oligodendrocytes, which are a group of cells that support neurons.

In multiple sclerosis, demyelination happens when the immune system inappropriately attacks and destroys the myelin, which makes communication between neurons break down, ultimately leading to all sorts of sensory, motor, and cognitive problems.

Now, the brain, including the neurons in the brain, is protected by things in the blood by the blood brain barrier, which only lets certain molecules and cells through from the blood.

For immune cells like T and B cells that means having the right ligand or surface molecule to get through the blood brain barrier, this is kind of like having the a VIP pass to get into an exclusive club.

Once a T cell makes its way in it can get activated by something it encounters - in the case of multiple sclerosis, it’s activated by myelin.

Once the T-cell gets activated, it changes the blood brain barrier cells to express more receptors, and this allows immune cells to more easily bind and get in, it’s kind of like bribing the bouncer to let in a lot of people.

Now, multiple sclerosis is a type IV hypersensitivity reaction, or cell-mediated hypersensitivity. And this means that those myelin specific T-cells release cytokines like IL-1, IL-6, TNF-alpha, and interferon-gamma, and together dilate the blood vessels which allows more immune cells to get in, as well as directly cause damage to the oligodendrocytes.

The cytokines also attract B-cells and macrophages as part of the inflammatory reaction.

Those B-cells begin to make antibodies that mark the myelin sheath proteins, and then the macrophages use those antibody markers to engulf and destroy the oligodendrocytes.

Without oligodendrocytes, there’s no myelin to cover the neurons, and this leaves behind areas of scar tissue, also called plaques or sclera.

In multiple sclerosis, these immune attacks typically happen in bouts.

In other words, an autoimmune attack on the oligodendrocytes might happen, and then regulatory T cells will come in to inhibit or calm down the other immune cells, leading to a reduction in the inflammation.

Early on in multiple sclerosis, the oligodendrocytes will heal and extend out new myelin to cover the neurons, which is a process called remyelination.

Unfortunately, though, over time as the oligodendrocytes die off the remyelination stops and the damage becomes irreversible with the loss of axons.

Just like other autoimmune diseases, the exact cause of multiple sclerosis is unknown, but is linked to both genetic and environmental factors.

Genetic risk factors include being a woman and having genes that encode a specific type of immune molecule called HLA-DR2 which is used to identify and bind to foreign molecules.

Environmental risk factors might include infections as well as vitamin D deficiency, which is an interesting one because it might help explain why the rates of multiple sclerosis are higher at the northern and southern poles compared to the equator where there’s a lot more sunlight.

Together these genetic and environmental influences might lead to the body not killing off immune cells that target myelin.

So it turns out that there are four main types of multiple sclerosis based on the pattern of symptoms over time. To break this down, we can use this graph with time on the x-axis, where time refers to the lifespan of the individual, and disability on the y-axis.

The first, and by far the most common pattern of multiple sclerosis, is called relapsing-remitting multiple sclerosis or RRMS. This condition is what we just described, bouts of autoimmune attacks happening months, or even years, apart, and causing an increase in the level of disability.

For example, during a bout a person may lose some vision, but then it may be followed by improvement if there’s remyelination.

Unfortunately, though, more often than not, the remyelination process is not complete so there is often some residual disability that remains, and that means that with each attack, more and more of the central nervous system gets irreversibly damaged.

In the relapsing-remitting multiple sclerosis type there’s typically no increase in disability between bouts, so the line stays flat during that time.

Now, the second type is called secondary progressive multiple sclerosis or SPMS which initially is pretty similar to the relapse-remitting type, but over time the immune attack becomes constant which causes a steady progression of disability.

The third type is primary-progressive multiple sclerosis or PPMS, which is basically one constant attack on myelin which causes a steady progression of disability over a person’s lifetime.

The final type is progressive relapsing multiple sclerosis or PRMS, which is also one constant attack but this time there are bouts superimposed during which the disability increases even faster.

Specific symptoms varying a lot from person to person, and largely depend on the location of the plaques.

Key Takeaways

Multiple sclerosis is a progressive, demyelinating disease on the central nervous system, characterized by the destruction of myelin, the protective sheath surrounding nerve cells, as well as inflammation and scarring of nerve fibers.

Damage to these nerves disrupts the ability of parts of the nervous system to transmit impulses, resulting in a wide range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Symptoms vary widely, but they may include muscle weakness, fatigue, vision problems, balance and coordination problems, and problems with memory and thinking.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine" McGraw Hill Education/ Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  5. "Multiple sclerosis" The Lancet (2008)
  6. "Defining the clinical course of multiple sclerosis: Results of an international survey" Neurology (1996)